Member Info for flava

Most people didn't read the RNS in details and understand why this is worth multiples of its current market cap in the long term. Some astute investors took advantage of the initial drop and are holding for a significant reward when the takeover or JV deal is announced. I believe this will rise and break the 40p resistance at some point and retest the 160p drop from December 2021.

RUA Life Sciences Trading Update

The company's Biomaterials and Contract Manufacturing businesses are performing in line with expectations and demonstrating growth potential.

The company is focused on minimising the future investment required to commercialise its development projects and reaching profitability and cash generation in a shorter timeframe.

Shares of RUA have spiked sharply in the past week in the wake of the well-received strategy update.

The market seems primed to resume enthusiasm given the prospects for accelerating cash generation.

Overall, the trading update is positive and suggests that RUA Life Sciences is on track to achieve its goals.

The company's focus on minimising investment and accelerating cash generation is likely to be welcomed by investors.

Someone paid 30p at 9:41am for 10k worth.

09:41:41 30.00 33,301 9,990

Worth watching this video (skip to 5:00min) https://www.youtube.com/watch?v=-U_ig4muGeM

1st in the world to launch non biologically sealed vascular graft

Well done pumpky. glad you made some money! No need to troll here mate. Goodluck!

If you were burned in HEMO and people trolled you onboard, then don't come here and do the same. You need to grow up and avoid making the same mistakes as others. Good luck with your investments.

This is why pumpky is so sad trolling here lol

Posted in: HEMO

Posts: 13,780

Price: 2.55

No Opinion

RE: Fun day16 Nov 2023 10:53

If/when the SP gets to 10 pence:everyone will be happy including Mrs Pumpky:I like to trade with my money xx

Don't look at the everyday movements of the SP; it will move like a rocket when the punters are back in full swing. GLA

RUA Life Sciences Trading Update

The company's Biomaterials and Contract Manufacturing businesses are performing in line with expectations and demonstrating growth potential.

The company is focused on minimising the future investment required to commercialise its development projects and reaching profitability and cash generation in a shorter timeframe.

Shares of RUA have spiked sharply in the past week in the wake of the well-received strategy update.

The market seems primed to resume enthusiasm given the prospects for accelerating cash generation.

Overall, the trading update is positive and suggests that RUA Life Sciences is on track to achieve its goals.

The company's focus on minimising investment and accelerating cash generation is likely to be welcomed by investors.

RUA Life Sciences (RUA), the holding company of a group of medical device businesses focused on the exploitation of the world’s leading long-term implantable biostable polymer, provided an unaudited trading update for the six-month period ended 30 September 2023. The company said taking into account the recent catch-up in shipments, its Biomaterials and Contract Manufacturing businesses continue to perform in line with expectations and demonstrate growth potential. As announced on 20 November with the Strategy Update its focus is to minimise the future investment required for the Group to commercialise its development projects and provide a pathway for the Group to reach profitability and cash generation in a significantly shorter timeframe.

Comment; Shares of RUA spiked sharply in the past week in the wake of the well received strategy update.

The market seems primed to resume the enthusiasm given the prospects for accelerating cash generation.

While the critics and naysayers continue to vocalise their negativity, I'm taking advantage of the current market conditions to buy and going to make a profit very soon.

One word from the company is no placing!

All the sad trolls here working together because they don't have family and friends to keep them company lol.

Get back to bed troll.

With a catch-up in order shipments together with the receipt of R&D Tax Credits of £381k, the cash position at 21 November 2023 stood at over £1.0m.

I will tell you when it goes to 100p after JV deal news.

One word from the company is no placing! Blue day on the day. GLA

23p buy was dirt cheap and well done to the buyer.

The good news is that no share placing is required, as everyone knew that the company was about to be taken over or enter into a joint venture deal.

I'm not concerned about the latest RNS, as this unaudited trading update for the six-month period is part of the due diligence process to ensure that the company is making progress ahead of the upcoming deal.

Biomaterials royalties increased to £199k, representing year on year growth of 6%.

No placing required. no the trolls can return to the hole. :)

Management Outlook:

The Group is confident that full-year revenues will align with management expectations for the current financial year.

The Group is focused on minimising the future investment required to commercialise its development projects and provide a pathway for the Group to reach profitability and cash generation in a significantly shorter timeframe.

Additional Notes:

The order disruption in the Contract Manufacture business was temporary and has already started to recover.

Costs remained tightly controlled despite the shortfall in revenues. The Group expects to announce its interim results in the second half of December 2023.

Your post is useless